Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinolin 2(1H) one. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109836383A reveals metal-free synthesis for 3,4-dihydroquinoline-2(1H)-one. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Patent CN102348691A details a high-yield process for quinolinone derivatives, replacing DMSO with xylene to drastically reduce impurities and enhance supply chain reliability for API manufacturing.
Novel phthalimide route for brexpiprazole intermediate offers high purity and yield, significantly reducing costs for API manufacturers.
Patent CN113416166B details a green silver-catalyzed route using CO2 and ionic liquids for high-purity pharmaceutical intermediates with simplified workup.
Novel palladium-catalyzed carbonylation patent offers cost-effective high-purity pharmaceutical intermediates with scalable supply chain reliability for global procurement teams.
Novel Pd-catalyzed aminocarbonylation method for quinolinone derivatives using benzisoxazoles. Offers cost reduction in API manufacturing and high purity.
Patent CN114478375A details a novel Pd-catalyzed reductive aminocarbonylation route. This method offers significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed carbonylation route for quinolinones using benzisoxazole. High yield, broad scope, cost-effective for API intermediates.
Patent CN113045489B details a novel Pd-catalyzed route to 3-arylquinolin-2(1H)ones using benzisoxazole, offering cost reduction in API manufacturing and scalable production.
Novel palladium-catalyzed route for quinolinone derivatives offers high yields and broad functional group tolerance for pharmaceutical intermediates.
Patent CN113045489B reveals a Pd-catalyzed route using benzisoxazole. Offers cost reduction and high purity for pharmaceutical manufacturing.
Patent CN113045489A details a novel Pd-catalyzed aminocarbonylation route for quinolin-2-ones, offering streamlined manufacturing and cost reduction in API intermediate production.
Novel Pd-catalyzed method using benzisoxazole for quinolinone derivatives. Offers cost-effective, scalable routes for pharmaceutical intermediates.
Patent CN114478375A details a novel Pd-catalyzed route to quinolin-2(1H)ones using o-nitrobenzaldehyde, offering cost reduction in API manufacturing and scalable supply.
Novel palladium-catalyzed aminocarbonylation route for quinolin-2(1H)-ones using benzisoxazole. High yields, scalable process for pharmaceutical intermediates.
Novel Pd-catalyzed aminocarbonylation route offers high yields and broad substrate tolerance for scalable pharmaceutical intermediate production.
Patent CN113045489B details a novel Pd-catalyzed route for quinolin-2(1H)ones, offering cost-effective API intermediate manufacturing with high functional group tolerance.
Novel Pd-catalyzed synthesis offers cost reduction in pharmaceutical intermediate manufacturing with high purity and scalable supply chain reliability for global buyers.
Patent CN114478375A reveals a novel Pd-catalyzed route to 3-alkenyl quinolin-2(1H)ones using allyl aryl ethers, offering safer carbonylation and cost reduction in API manufacturing.
Novel Pd-catalyzed carbonylation route for quinolinone derivatives offers high yields and broad functional group tolerance for pharmaceutical manufacturing.